Glenmark cuts Fabiflu price by 27% | WeForNews | Latest News, Blogs Glenmark cuts Fabiflu price by 27% – WeForNews | Latest News, Blogs
Connect with us

Disaster

Glenmark cuts Fabiflu price by 27%

On June 20, Glenmark announced that it received manufacturing and marketing approval from India”s drug regulator for FabiFlu, making it the first oral Favipiravir-approved medication in India for the treatment of mild to moderate COVID-19.

Published

on

Glenmark Fabiflu

New Delhi, July 13 : Glenmark Pharmaceuticals has announced that it has commenced a Post Marketing Surveillance (PMS) study on FabiFlu to closely monitor the efficacy and safety of the drug in 1000 Covid patients that are prescribed with the oral antiviral.

Further, Glenmark has announced a price reduction of 27 per cent for FabiFlu. The new MRP is Rs 75 per tab from the earlier Rs 103 per tab.

The price reduction has been made possible through benefits gained from higher yields and better scale, as both the API and formulations are made at Glenmark”s facilities in India, the benefits of which are being passed on to patients in the country.

Glenmark has successfully developed the active pharmaceutical ingredient (API) and the formulation for FabiFlu through its own in-house R&D team within the country, ensuring self-reliance with regard to long term production and manufacturing.

Commenting on these developments, Alok Malik, Senior Vice President & Head – India business, Glenmark Pharmaceuticals said, “We expect this post marketing surveillance study to shed more light on the drug”s clinical effectiveness and safety in a large cohort of patients prescribed FabiFlu. Our priority from the start of this pandemic has been to offer patients in India an effective treatment for COVID-19, while also ensuring accessibility to the masses.

“Our internal research shows us that we launched FabiFlu in India at the lowest market cost as compared to the cost of Favipiravir in other countries where it is approved. And now we hope that this further price reduction will make it even more accessible for patients across the country.”

Despite investing significantly in R&D, clinical trials and the manufacturing of FabiFlu (API and formulations), Glenmark has managed to keep the pricing of FabiFlu lower as compared to its price in other countries.

FabiFlu in India was originally launched at Rs 103 per tablet, while, its price in Indian Rupees is higher in the remaining countries like Rs 600 in Russia, Rs 378 in Japan, Rs 350 in Bangladesh and Rs 215 in China.

On June 20, Glenmark announced that it received manufacturing and marketing approval from India”s drug regulator for FabiFlu, making it the first oral Favipiravir-approved medication in India for the treatment of mild to moderate COVID-19.

The manufacturing and marketing approval was granted as part of accelerated approval process, considering the emergency situation of the COVID-19 outbreak in India. The approval”s restricted use entails responsible medication use where every patient must have signed informed consent before treatment initiation.

Cities

Maharashtra scales new high with 400-plus Covid deaths, cases above 11K

The state registered 413 Covid deaths – surpassing the 390 fatalities reported on August 9, along with 11,813 new cases.

Published

on

By

Coronavirus Isolation ward

Maharashtra’s daily Covid-19 death toll crossed the 400 mark on Thursday while new cases again shot above the 11,000 mark, health officials said.

The state registered 413 Covid deaths – surpassing the 390 fatalities reported on August 9, along with 11,813 new cases.

The state death toll has now shot up to 19,063, while the total number of cases went up to 560,126 – both highest in the country.

According to Thursday’s figures, there was one death roughly every 3 minutes and 492 new cases every hour.

The state recovery rate dropped from 69.64 per cent to 69.08 per cent on Thursday, while the mortality rate stood stable at 3.04 per cent.

Meanwhile, a total of 9,115 recovered patients returned home, taking the total number of discharged patients to 390,958 – considerably higher than the 149,798 active cases currently.

Of the fresh fatalities, Pune again topped with 92 deaths, followed by 65 fatalities in Thane and 48 in Mumbai.

There were also 36 deaths in Kolhapur, 20 in Satara, 15 each in Raigad, Nashik, Jalgaon, and Nagpur, 12 in Palghar, 11 in Latur, 10 in Sangli, nine in Osmanabad, eight in Ahmednagar, six in Solapur, five in Dhule, four in Nanded, threee each in Parbhani and Beed, 2 each in Ratnagiri, Jalna, Hingoli, Akola, Amravati, Yavatmal, Buldhana, and Gondiya, and one each in Nandurbar, Sindhudurg, Aurangabad, Washim and Chandrapur.

Mumbai’s toll has now increased to 6,991 and the number of cases increased by 1,200 to 127,556.

The MMR (Thane division) has seen the toll shooting up by the highest – 140 – to reach 11,201 deaths, while fresh 3,395 new cases took its total to 278,969.

Pune district cases have reached 122,020 with the death toll increasing to 2,957, while Thane district has 109,703 cases with 3,190 fatalities.

With 118 more fatalities, the Pune division’s death toll reached 3,774 and the case tally zoomed up with 3,034 new cases to 141,727.

Nashik division has recorded 1,597 fatalities and 56,891 cases, followed by Aurangabad division with 730 deaths and 22,569 cases, Kolhapur division with 583 fatalities and 20,419 cases, Latur division with 435 fatalities and 13,591 cases, Akola division with 351 fatalities and 11,327 cases, and Nagpur division with 334 deaths and 14,047 cases.

Meanwhile, the number of people sent to home quarantine increased to 10,25,660, while those in institutional quarantine increased to 36,450.

Continue Reading

Disaster

5.5-magnitude earthquake rattles northern Philippines

Published

on

Earthquake

MANILA, Aug. 13 : An earthquake with a preliminary magnitude of 5.5 shook Batanes province in the northern Philippines on Thursday, the Philippine Institute of Seismology and Volcanology (Phivolcs) said.

The institute said the quake, which struck at 6:32 a.m. local time, hit at a depth of 14 kilometers, about 49 kilometers southwest of Sabtang town.

The institute said the quake, which was tectonic in origin, will trigger aftershocks but will not cause damage.

The Philippines has frequent seismic activity due to its location along the Pacific “Ring of Fire.”

Continue Reading

Disaster

5.3-magnitude quake hits 62 km SW of Surab, Pakistan: USGS

Published

on

Earthquake Strong

NEW YORK, Aug. 12 : An earthquake with a magnitude of 5.3 jolted 62 km southwest of Surab, Pakistan at 22:40:45 GMT on Wednesday, the U.S. Geological Survey said.

The epicenter, with a depth of 10.96 km, was initially determined to be at 27.9781 degrees north latitude and 65.9996 degrees east longitude.

Continue Reading
Advertisement

Most Popular

Corona Virus (COVID-19) Live Data

COVID-19 affects different people in different ways. Most infected people will develop mild to moderate illness and recover without hospitalization.